PDL BIOPHARMA, INC. 4
4 · PDL BIOPHARMA, INC. · Filed Jan 3, 2008
Insider Transaction Report
Form 4
Iwanicki David
VP, Sales & Sales Operations
Transactions
- Sale
Common Stock
[F1][F2]2008-01-02$17.41/sh−50$871→ 297 total - Sale
Commom Stock
[F1][F2]2008-01-02$17.06/sh−85$1,450→ 212 total - Sale
Common Stock
[F1][F2]2008-01-02$17.12/sh−27$462→ 185 total - Sale
Common Stock
[F1][F2]2008-01-02$17.14/sh−20$343→ 155 total - Sale
Common Stock
[F1][F2]2008-01-02$17.19/sh−95$1,633→ 60 total - Sale
Common Stock
[F1][F2]2008-01-02$17.26/sh−60$1,036→ 0 total
Footnotes (2)
- [F1]Sale was made pursuant to a 10b5-1 plan established by the reporting person.
- [F2]Shares acquired under a Section 423 employee stock purchase plan on June 29, 2007.
Signature
/s/ Andrew Guggenhime by Andrew Guggenhime, Attorney- in- Fact for David Iwanicki|2008-01-03